ArticleFrontiers in clinical diabetes and healthcare2025
A pilot study for an integrated diabetes screening, referral, and care program within a low-income community in Mexico.
Article in Frontiers in clinical diabetes and healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine the feasibility and acceptability of a coordinated community-based intervention for low-income adults with type 2 diabetes (T2D) that included (1) screening and referral, (2) shared decision-making (SDM), and (3) diabetes self-management education and support (DSMES). Methods: Participants were screened for T2D through a mobile health unit in a low-income community in Guadalajara, Jalisco, Mexico, and referred for follow-up in a primary care health center serving that community. Primary care physicians (PCPs) within the health center were trained on SDM for T2D, and community health workers (CHWs) were trained to deliver DSMES. Feasibility was measured by the number of community members screened and referred for care, the number of PCPs implementing SDM, and the number of CHWs hired and trained on DSMES. Acceptability was assessed by the percentage of participants who completed the 3-month DSMES program. Potential clinical impact was determined by effect sizes of changes in HbA1c between baseline and 3 months. Other measurements included waist circumference (WC), body weight, diabetes distress, and diabetes self-care activities, assessed at baseline, and at 1 and 3 months during the study period. Results: With respect to feasibility, all PCPs from the clinic completed the SDM training and were able to implement it in their primary practice. The DSMES training was completed by 4 (50%) of CHWs, and 3 were selected to deliver the course to study participants. Related to acceptability, 182 community members were screened, of which 42 were eligible for participation and 23 were successfully enrolled. Out of six programmed sessions, average participant attendance was 80% with 60.9% of participants retained at three months. Changes in HbA1c from baseline to 3 months were 10.1 ± 2.7 to 9.4 ± 3.1. Discussion: The use of community screening to refer low-income people living with T2D to a clinic-based SDM and DSMES intervention was feasible with large effect sizes for changes in HbA1c. The high attrition rates suggest that alternative strategies may be necessary to keep patients engaged in care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.